With regards to indications for lung transplant, the prevalence of CHIP has been best evaluated in individuals with chronic obstructive pulmonary disease (COPD), where it was identified in 6% of patients with COPD of a similar age range as our cohort [42]. The gene discussed is STUB1; the disease is chronic obstructive pulmonary disease.